[Image from Lokavant]
In an industry where each lost day can drain roughly $40,000 in direct clinical-trial costs, Lokavant says its newly launched Spectrum v15 can crunch data from 500,000 past studies and deliver enrollment forecasts in five minutes, work that typically takes study teams five weeks. The company claims that the platform boasts 80+% confidence.
The company, spun out from Roivant Sciences, designed Spectrum v15 to overcome the limitations of traditional feasibility analysis….
